financetom
Business
financetom
/
Business
/
GR Silver Mining Drills Wide Silver Intercepts at San Marcial
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GR Silver Mining Drills Wide Silver Intercepts at San Marcial
Aug 21, 2025 5:56 AM

08:20 AM EDT, 08/21/2025 (MT Newswires) -- GR Silver Mining ( GRSLF ) on Thursday provided drilling results from the ongoing Step-Out Drilling Program adjacent to the 2023 NI 43-101 mineral resource at the San Marcial Area, Plomosas project, in Sinaloa, Mexico.

The company said drilling at hole SMS25-08 successfully discovered a new high-grade gold-silver epithermal vein and intersected a wide, predominantly silver-mineralized intercept hosted in hydrothermal breccia. Hole SMS25-07A intersected multiple zones of wide silver mineralization at shallow depth.

It said hole SMS25-08 was drilled to test the down-dip continuity of silver mineralization 45 metres below historical trench results, targeting a perpendicular orientation to the northeast structures and their intersections with northwest-oriented regional structures. The presence of mineralization at these intersections oriented towards the northeast represents a "potential opportunity for resource expansion at this target."

"Each batch of drill results received from the step-out drilling program increases the prospective scale of the San Marcial Area, potentially unlocking a much larger resource," said GR Silver Mining ( GRSLF ) Chief Executive Marcio Fonseca. "The continuity of high silver grades and broad widths of predominant silver mineralization encountered at shallow depths, as revealed by the step-out drilling, supports the opportunity to continue drilling and expanding resources in the vicinity of the San Marcial Resource Area."

"We await additional assay results now from the SE Deep Extension target, which we believe will potentially lead to an extension of mineralization below existing resource boundaries," said Fonseca.

Shares of the company closed up 6.7% to $0.16 on Wednesday on the TSX Venture Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
HAFNIA LIMITED: Hafnia Completes Acquisition of 13.97% of TORM
HAFNIA LIMITED: Hafnia Completes Acquisition of 13.97% of TORM
Mar 10, 2026
SINGAPORE--(BUSINESS WIRE)-- With reference to the stock exchange announcement of 18 December 2025, in which Hafnia Limited ( HAFN ) announced that all conditions precedent for completion of the share purchase agreement (the “Share Purchase Agreement”) entered into with Oaktree Capital Management, L.P. and its affiliates (together, Oaktree), have been satisfied, Hafnia ( HAFN ) is pleased to announce that...
Silicon Valley Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering
Silicon Valley Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering
Mar 10, 2026
PALO ALTO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Silicon Valley Acquisition Corp. (the “Company”) announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit on December 22, 2025. The units are expected to be listed for trading on the Nasdaq Stock Market LLC under the ticker symbol “SVAQU” beginning December 23,...
Integra Resources Up 2% In US After Hours As Retires US$15 Million Beedie Capital Convertible Debenture
Integra Resources Up 2% In US After Hours As Retires US$15 Million Beedie Capital Convertible Debenture
Mar 10, 2026
04:36 PM EST, 12/22/2025 (MT Newswires) -- Integra Resources ( ITRG ) was at last look up 2% in US after hours trade Monday, while it has also touched a fresh 52 week high, as it announced the full conversion and repayment of the Beedie Investment convertible debenture facility. The company said it issued nearly 12.3 million common shares at...
Neurocrine's Phase 3 Trial of Valbenazine in Dyskinetic Cerebral Palsy Fails to Meet Primary, Key Secondary Endpoints
Neurocrine's Phase 3 Trial of Valbenazine in Dyskinetic Cerebral Palsy Fails to Meet Primary, Key Secondary Endpoints
Mar 10, 2026
04:36 PM EST, 12/22/2025 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Monday its phase 3 trial assessing the efficacy, safety, and tolerability of valbenazine in pediatric and adult participants with dyskinetic cerebral palsy did not meet primary or key secondary endpoints. The primary goal of the trial was to evaluate improvement in chorea, which is a type of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved